Sign up to save your podcasts
Or
Share Bangkok's New Playbook: Pure Global on Cracking ASEAN's MedTech Harmonization Code.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Bangkok's New Playbook: Pure Global on Cracking ASEAN's MedTech Harmonization Code.
This week, we dive into the most significant announcement from the International Healthcare Week in Bangkok: the launch of the 'ASEAN Device Accord'. This pioneering pilot program by Thailand and Singapore aims to create a single, unified registration pathway for medical devices, potentially ending the era of fragmented and costly market access in the region.
We break down how this joint-review system will work, which device classes are targeted, and the massive implications for MedTech innovators. This isn't just a policy update; it's a strategic shift that could unlock the combined potential of two of ASEAN's most dynamic markets, setting a precedent for the rest of the region.
**Case Study:** A European MedTech startup has developed an advanced, non-invasive blood sugar monitor. Their primary obstacle to entering the lucrative ASEAN market is the prohibitive cost and time required to file separate, customized registration dossiers in both Singapore and Thailand. The newly announced ASEAN Device Accord could slash their market entry timeline and costs by more than half, allowing them to compete with larger players far more quickly.
**What You'll Learn:**
- What is the 'ASEAN Device Accord' and what does it mean for your business?
- How will the joint Thai-Singaporean review process actually function?
- Which specific medical devices are included in this groundbreaking pilot?
- What are the hidden regulatory challenges in post-market surveillance under this new system?
- Why is this initiative a game-changer for accessing the ASEAN market?
- How should you prepare your technical dossier now to capitalize on this opportunity?
- Could this be the first concrete step towards a single ASEAN medical device regulator?
Navigating cross-border regulatory shifts like the ASEAN Device Accord is where expertise matters. Pure Global offers end-to-end regulatory consulting, leveraging local experts in over 15 offices and advanced AI tools to streamline your global market access. Let us help you turn regulatory complexity into a competitive advantage. Contact us at [email protected] or visit https://pureglobal.com/.
View all episodes
By Ran ChenThis week, we dive into the most significant announcement from the International Healthcare Week in Bangkok: the launch of the 'ASEAN Device Accord'. This pioneering pilot program by Thailand and Singapore aims to create a single, unified registration pathway for medical devices, potentially ending the era of fragmented and costly market access in the region.
We break down how this joint-review system will work, which device classes are targeted, and the massive implications for MedTech innovators. This isn't just a policy update; it's a strategic shift that could unlock the combined potential of two of ASEAN's most dynamic markets, setting a precedent for the rest of the region.
**Case Study:** A European MedTech startup has developed an advanced, non-invasive blood sugar monitor. Their primary obstacle to entering the lucrative ASEAN market is the prohibitive cost and time required to file separate, customized registration dossiers in both Singapore and Thailand. The newly announced ASEAN Device Accord could slash their market entry timeline and costs by more than half, allowing them to compete with larger players far more quickly.
**What You'll Learn:**
- What is the 'ASEAN Device Accord' and what does it mean for your business?
- How will the joint Thai-Singaporean review process actually function?
- Which specific medical devices are included in this groundbreaking pilot?
- What are the hidden regulatory challenges in post-market surveillance under this new system?
- Why is this initiative a game-changer for accessing the ASEAN market?
- How should you prepare your technical dossier now to capitalize on this opportunity?
- Could this be the first concrete step towards a single ASEAN medical device regulator?
Navigating cross-border regulatory shifts like the ASEAN Device Accord is where expertise matters. Pure Global offers end-to-end regulatory consulting, leveraging local experts in over 15 offices and advanced AI tools to streamline your global market access. Let us help you turn regulatory complexity into a competitive advantage. Contact us at [email protected] or visit https://pureglobal.com/.